PTK2B and breast carcinoma: In contrast, reduction of Pyk2 activity through genetic engineering and pharmacological inhibition abrogated the ability of breast cancer cells to form orthotopic mammary tumors and undergo invasion, and inhibited the metastatic outgrowth of disseminated breast cancer cells in the lungs of mice.